COMPARE · Reviewed July 29, 2026
MMM vs PAM
Verdict: Side-by-side breakdown using the Bull Rankings model. MMM scored 50.2, PAM scored 53.2 — PAM leads.
Compare another set
MMM
3M Company
50.2
$176.47 · $91.0B
fundamentals as of
Score gap
3.0
PAM leads
PAM
Pampa Energía S.A.
53.2
$89.02 · $4.8B
fundamentals as of
The model, pillar by pillar (0–100 each)
MMM
stronger →← stronger
PAM
71
Qualityreturns · margins · balance sheet
58
51
Growthrevenue & earnings expansion
73
35
Valuevaluation vs sector peers
36
MMM and PAM split the three pillars evenly.
Fundamentals, head-to-head
MMM
PAM
$4.0bB
FCF
-$12mF
+2.3%C
Rev
+8.3%B
4.38D
D/E
0.50B+
31.4xB
P/E
—
1.83C+
PEG
1.58C+
—
P/S
2.6xB
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
MMM
PAM
46% above
Price vs fair valuelower is cheaper
—
~16%/yr
Growth the price implies10-yr FCF · lower = less priced in
—
-36%
1-yr DCF upside
—
-31%
5-yr DCF upside
—
-24%
10-yr DCF upside
—
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
MMM
Why this score
- Buying back stock
- Raising its dividend
PAM
No notable signals flagged.
The companies
MMM3M Company
Why now
Conglomerates · market cap $91.0b. 5% off the 52-week high of $184.90. 17 sell-side analysts rate this a Buy with a mean 1-yr target of $181.85 (implying +3% upside).
Moat
FCF converts 133% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined. $91.0b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
D/E 4.38 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Trailing P/E 31x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
PAMPampa Energía S.A.
Why now
Conglomerates · market cap $4.8b. 6% off the 52-week high of $94.50. 11 sell-side analysts rate this a Buy with a mean 1-yr target of $117.59 (implying +32% upside).
Moat
Net margin 33% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 19% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Free cash flow is negative (-$12m) — capital raises or debt issuance likely required; dilution / leverage risk.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.